Evidence map›Paper›PMID 42730362›Full record

ArticleMediterranean journal of hematology and infectious diseases2026

A Case of Pseudo-Richter Transformation Following Zanubrutinib Discontinuation in CLL.

Luca Laurenti, Tommaso Quaranta, Annamaria Tomasso, Luca Stirparo, Pier Luigi Abbate, Arianna Bakacs, Natalia Cappoli, Arianna Di Napoli, Dimitar Efremov, Flaminia Bellisario and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Mediterranean journal of hematology and infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Luca LaurentiUOSD Leucemia Linfatica Cronica, Dipartimento di scienze di laboratorio ed ematologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.
Tommaso QuarantaUniversità Cattolica del Sacro Cuore, Istituto di Ematologia, Roma, Italy.
Annamaria TomassoUOSD Leucemia Linfatica Cronica, Dipartimento di scienze di laboratorio ed ematologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.
Luca StirparoUOSD Leucemia Linfatica Cronica, Dipartimento di scienze di laboratorio ed ematologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.
Pier Luigi AbbateUniversità Cattolica del Sacro Cuore, Istituto di Ematologia, Roma, Italy.
Arianna BakacsUniversità Cattolica del Sacro Cuore, Fondazione Policlinico Gemelli Roma, Istituto di Patologia, Roma, Italy.
Natalia CappoliUniversità Cattolica del Sacro Cuore, Fondazione Policlinico Gemelli Roma, Istituto di Patologia, Roma, Italy.
Arianna Di NapoliPathology Unit, Department of Clinical and Molecular Medicine, Sant'Andrea University Hospital, Sapienza University of Rome, Roma, Italy.
Dimitar EfremovDepartment of Medical Sciences, Macedonian Academy of Sciences and Arts, Skopje, North Macedonia.
Flaminia BellisarioFondazione Policlinico Universitario A. Gemelli IRCCS, UOSD Malattie Linfoproliferative Extramidollari, Dipartimento di scienze di laboratorio ed ematologiche, Roma, Italy.
Valter GatteiClinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
Carmelo CaldarellaUnit of Nuclear Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.
Maria Lucia CalcagniUnit of Nuclear Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.
Francesco AutoreUOSD Leucemia Linfatica Cronica, Dipartimento di scienze di laboratorio ed ematologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.
Idanna InnocentiUOSD Leucemia Linfatica Cronica, Dipartimento di scienze di laboratorio ed ematologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BTK inhibitorsChronic lymphocytic leukaemiaPseudo-richterZanubrutinib

Identifiers

PMID42730362
PMCPMC13568486

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.